It was reported that on (b)(6) 2023, a patient presented with grade 4 degenerative mitral regurgitation (mr) and a prolapsed posterior 3 (p3) segment for a mitraclip procedure.One mitraclip ntw was implanted successfully on anterior 3 (a3) / p3.The mr was reduced to grade <1.The patient was discharged after a transthoracic echocardiogram (tte) on 24mar2023.On 17may2023, during a follow-up tte, a single leaflet device attachment (slda) was observed.The posterior mitral leaflet (pml) was detached.The mr was recurrent at grade 3-3+, commissural and medial from the slda.The patient was symptomatic with heart failure symptoms of fatigue and dyspnea.The slda was likely due to the prolapse becoming detached.On 15dec2023, a second clip intervention was performed.One ntw was implanted commissural at a3/p3.The mr was reduced to grade 1.The patient is stable.There were no adverse patient sequelae or clinically significant delay.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.All available information was investigated, and the reported single leaflet device attachment (slda) per the physician is related to patient anatomy.The reported mr, dyspnea, fatigue and hf are cascading effects of the reported incomplete coaptation.Additionally, the reported patient effect of mr, dyspnea, fatigue, hf are listed in the instructions for use, and are known possible complications associated with mitraclip procedures.The reported hospitalization and medical intervention were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|